Subsequently we confirmed both in vivo and in vitro experiments that TDO2 and miR-126-5p mimics can promote the proliferation, invasion and migration of HCC cells, while knockdown TDO2 and miR-126-5p inhibitors can inhibit the tumor progression of HCC cells. Here, TDO2 is linked to hepatocellular carcinoma.